Quarterly Transactions Made in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE). The information is specifically focused on institutions that hold shares of Ultragenyx Pharmaceutical Inc..
Shares Purchased
Shares Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 5,851,137 | 2,407,985 | 8,259,122 | 4,512,078 | 1,180,502 | 5,692,580 | 2,566,542 | |
Q4 2021 | 3,388,382 | 3,095,036 | 6,483,418 | 4,427,595 | 221,088 | 4,648,683 | 1,834,735 | |
Q1 2022 | 2,958,677 | 1,042,266 | 4,000,943 | 3,899,022 | 1,292,677 | 5,191,699 | -1,190,756 | |
Q2 2022 | 5,008,161 | 2,313,908 | 7,322,069 | 4,560,812 | 875,293 | 5,436,105 | 1,885,964 | |
Q3 2022 | 7,739,032 | 5,306,857 | 13,045,889 | 9,512,682 | 12,509 | 9,525,191 | 3,520,698 | |
Q4 2022 | 9,321,605 | 2,339,197 | 11,660,802 | 8,398,003 | 0 | 8,398,003 | 3,262,799 | |
Q1 2023 | 5,628,366 | 1,339,138 | 6,967,504 | 5,282,927 | 117,173 | 5,400,100 | 1,567,404 | |
Q2 2023 | 5,098,064 | 3,862,046 | 8,960,110 | 7,486,490 | 669,270 | 8,155,760 | 804,350 | |
Q3 2023 | 5,161,153 | 1,538,553 | 6,699,706 | 3,437,487 | 765,133 | 4,202,620 | 2,497,086 | |
Q4 2023 | 12,557,050 | 7,810,920 | 20,367,970 | 3,471,759 | 0 | 3,471,759 | 16,896,211 | |
Q1 2024 | 5,011,353 | 6,218,463 | 11,229,816 | 5,447,189 | 0 | 5,447,189 | 5,782,627 | |
Q2 2024 | 14,588,261 | 2,914,349 | 17,502,610 | 6,976,565 | 0 | 6,976,565 | 10,526,045 | |
Q3 2024 | 7,857,657 | 1,391,923 | 9,249,580 | 9,943,865 | 3 | 9,943,868 | -694,288 |